vs
Side-by-side financial comparison of AMN HEALTHCARE SERVICES INC (AMN) and APTARGROUP, INC. (ATR). Click either name above to swap in a different company.
APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $748.2M, roughly 1.3× AMN HEALTHCARE SERVICES INC). APTARGROUP, INC. runs the higher net margin — 7.7% vs -1.0%, a 8.8% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 1.8%). APTARGROUP, INC. produced more free cash flow last quarter ($96.9M vs $67.6M). Over the past eight quarters, APTARGROUP, INC.'s revenue compounded faster (2.6% CAGR vs -4.5%).
AMN Healthcare Services Inc. is a leading US healthcare sector workforce solutions and staffing provider. It offers temporary and permanent placement for nurses, physicians, allied health and other clinical/non-clinical staff, plus workforce management tools and consulting for hospitals, clinics and other medical facilities.
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
AMN vs ATR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $748.2M | $962.7M |
| Net Profit | $-7.7M | $74.3M |
| Gross Margin | 26.1% | — |
| Operating Margin | 1.1% | 11.0% |
| Net Margin | -1.0% | 7.7% |
| Revenue YoY | 1.8% | 13.5% |
| Net Profit YoY | 95.9% | -26.4% |
| EPS (diluted) | $-0.19 | $1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $748.2M | $962.7M | ||
| Q3 25 | $634.5M | $961.1M | ||
| Q2 25 | $658.2M | $966.0M | ||
| Q1 25 | $689.5M | $887.3M | ||
| Q4 24 | $734.7M | $848.1M | ||
| Q3 24 | $687.5M | $909.3M | ||
| Q2 24 | $740.7M | $910.1M | ||
| Q1 24 | $820.9M | $915.4M |
| Q4 25 | $-7.7M | $74.3M | ||
| Q3 25 | $29.3M | $127.9M | ||
| Q2 25 | $-116.2M | $111.7M | ||
| Q1 25 | $-1.1M | $78.8M | ||
| Q4 24 | $-187.5M | $100.9M | ||
| Q3 24 | $7.0M | $100.0M | ||
| Q2 24 | $16.2M | $90.5M | ||
| Q1 24 | $17.3M | $83.1M |
| Q4 25 | 26.1% | — | ||
| Q3 25 | 29.1% | — | ||
| Q2 25 | 29.8% | — | ||
| Q1 25 | 28.7% | — | ||
| Q4 24 | 29.8% | — | ||
| Q3 24 | 31.0% | — | ||
| Q2 24 | 31.0% | — | ||
| Q1 24 | 31.4% | — |
| Q4 25 | 1.1% | 11.0% | ||
| Q3 25 | 7.5% | 14.2% | ||
| Q2 25 | -18.8% | 14.9% | ||
| Q1 25 | 1.8% | 12.8% | ||
| Q4 24 | -27.6% | 14.2% | ||
| Q3 24 | 3.2% | 15.2% | ||
| Q2 24 | 5.1% | 13.8% | ||
| Q1 24 | 4.9% | 12.2% |
| Q4 25 | -1.0% | 7.7% | ||
| Q3 25 | 4.6% | 13.3% | ||
| Q2 25 | -17.7% | 11.6% | ||
| Q1 25 | -0.2% | 8.9% | ||
| Q4 24 | -25.5% | 11.9% | ||
| Q3 24 | 1.0% | 11.0% | ||
| Q2 24 | 2.2% | 9.9% | ||
| Q1 24 | 2.1% | 9.1% |
| Q4 25 | $-0.19 | $1.13 | ||
| Q3 25 | $0.76 | $1.92 | ||
| Q2 25 | $-3.02 | $1.67 | ||
| Q1 25 | $-0.03 | $1.17 | ||
| Q4 24 | $-4.90 | $1.48 | ||
| Q3 24 | $0.18 | $1.48 | ||
| Q2 24 | $0.42 | $1.34 | ||
| Q1 24 | $0.45 | $1.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.0M | $409.5M |
| Total DebtLower is stronger | $767.1M | $1.1B |
| Stockholders' EquityBook value | $642.1M | $2.7B |
| Total Assets | $2.1B | $5.3B |
| Debt / EquityLower = less leverage | 1.19× | 0.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.0M | $409.5M | ||
| Q3 25 | $52.6M | $264.8M | ||
| Q2 25 | $41.5M | $169.8M | ||
| Q1 25 | $55.8M | $136.8M | ||
| Q4 24 | $10.6M | $226.2M | ||
| Q3 24 | $30.6M | $327.9M | ||
| Q2 24 | $48.0M | $223.9M | ||
| Q1 24 | $50.6M | $201.1M |
| Q4 25 | $767.1M | $1.1B | ||
| Q3 25 | — | $546.0M | ||
| Q2 25 | — | $535.1M | ||
| Q1 25 | — | $561.2M | ||
| Q4 24 | $1.1B | $688.1M | ||
| Q3 24 | — | $822.7M | ||
| Q2 24 | — | $681.5M | ||
| Q1 24 | — | $680.4M |
| Q4 25 | $642.1M | $2.7B | ||
| Q3 25 | $644.4M | $2.8B | ||
| Q2 25 | $607.6M | $2.7B | ||
| Q1 25 | $715.1M | $2.5B | ||
| Q4 24 | $706.6M | $2.5B | ||
| Q3 24 | $890.7M | $2.5B | ||
| Q2 24 | $876.9M | $2.4B | ||
| Q1 24 | $854.2M | $2.3B |
| Q4 25 | $2.1B | $5.3B | ||
| Q3 25 | $2.1B | $5.1B | ||
| Q2 25 | $2.2B | $4.9B | ||
| Q1 25 | $2.4B | $4.5B | ||
| Q4 24 | $2.4B | $4.4B | ||
| Q3 24 | $2.7B | $4.6B | ||
| Q2 24 | $2.8B | $4.5B | ||
| Q1 24 | $2.9B | $4.4B |
| Q4 25 | 1.19× | 0.43× | ||
| Q3 25 | — | 0.20× | ||
| Q2 25 | — | 0.20× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | 1.49× | 0.28× | ||
| Q3 24 | — | 0.32× | ||
| Q2 24 | — | 0.28× | ||
| Q1 24 | — | 0.29× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.6M | $183.7M |
| Free Cash FlowOCF − Capex | $67.6M | $96.9M |
| FCF MarginFCF / Revenue | 9.0% | 10.1% |
| Capex IntensityCapex / Revenue | 1.1% | 9.0% |
| Cash ConversionOCF / Net Profit | — | 2.47× |
| TTM Free Cash FlowTrailing 4 quarters | $233.8M | $299.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.6M | $183.7M | ||
| Q3 25 | $22.7M | $177.6M | ||
| Q2 25 | $78.5M | $126.0M | ||
| Q1 25 | $92.7M | $82.7M | ||
| Q4 24 | $72.8M | $178.2M | ||
| Q3 24 | $66.7M | $229.3M | ||
| Q2 24 | $99.5M | $143.6M | ||
| Q1 24 | $81.4M | $92.3M |
| Q4 25 | $67.6M | $96.9M | ||
| Q3 25 | $14.8M | $114.3M | ||
| Q2 25 | $68.7M | $62.5M | ||
| Q1 25 | $82.7M | $25.9M | ||
| Q4 24 | $56.6M | $112.2M | ||
| Q3 24 | $47.4M | $162.7M | ||
| Q2 24 | $72.2M | $75.4M | ||
| Q1 24 | $63.2M | $16.7M |
| Q4 25 | 9.0% | 10.1% | ||
| Q3 25 | 2.3% | 11.9% | ||
| Q2 25 | 10.4% | 6.5% | ||
| Q1 25 | 12.0% | 2.9% | ||
| Q4 24 | 7.7% | 13.2% | ||
| Q3 24 | 6.9% | 17.9% | ||
| Q2 24 | 9.8% | 8.3% | ||
| Q1 24 | 7.7% | 1.8% |
| Q4 25 | 1.1% | 9.0% | ||
| Q3 25 | 1.2% | 6.6% | ||
| Q2 25 | 1.5% | 6.6% | ||
| Q1 25 | 1.4% | 6.4% | ||
| Q4 24 | 2.2% | 7.8% | ||
| Q3 24 | 2.8% | 7.3% | ||
| Q2 24 | 3.7% | 7.5% | ||
| Q1 24 | 2.2% | 8.3% |
| Q4 25 | — | 2.47× | ||
| Q3 25 | 0.77× | 1.39× | ||
| Q2 25 | — | 1.13× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | 1.77× | ||
| Q3 24 | 9.54× | 2.29× | ||
| Q2 24 | 6.13× | 1.59× | ||
| Q1 24 | 4.70× | 1.11× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMN
| Travel Nurse Staffing | $208.3M | 28% |
| Allied Staffing | $146.9M | 20% |
| Labor Disruption Services | $124.3M | 17% |
| Technology And Workforce Solutions | $88.0M | 12% |
| Language Services | $69.9M | 9% |
| Other | $29.6M | 4% |
| International Nurse Staffing | $29.6M | 4% |
| Interim Leadership Staffing | $24.1M | 3% |
| Vendor Management Systems | $16.3M | 2% |
| Local Staffing | $8.6M | 1% |
| International Nurse Permanent Placement | $2.6M | 0% |
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
